Christopher Mason - 10 Jun 2021 Form 4 Insider Report for AVROBIO, Inc. (TECX)

Role
Chief Scientific Officer
Signature
/s/ Christopher Gerry, Attorney in Fact for Christopher Mason
Issuer symbol
TECX
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
14 Jun 2021, 18:03:04 UTC
Next filing
02 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Stock Option (Right to Buy) Award $0 +125,000 $0.000000 125,000 10 Jun 2021 Common Stock 125,000 $9.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares shall vest and become exercisable on June 10, 2023, and the remaining 50% shall vest and become exercisable on June 10, 2024.